Hooper Holmes, Inc.
560 N. Rogers Road
Olathe, KS 66062
Tel: 913-764-1045
Hooper–Provant combined entity will be is the largest Health &
Wellness examiner network in the U.S. and the only end-to-end
Health & Wellness provider
Screened over 500,000 individuals in 2015; Additional ~250,000
individuals on portal
Serving over 3,000 employers; 200 direct clients and 95+ channel
partners
$7.2 billion Corporate Wellness industry grew 6.3% in the U.S. in
2015, expected to grow avg. 7.8% annually, to $10.5 billion, by 2020*
Biometric collections clinical research market $2.5B**
FY ‘16 - $34.3mm Health & Wellness revenue - YTD Revenue
increased 6.7% compared to 2015
Adjusted EBITDA near break-even
Higher percentage of FY revenues from top Channel Partner
and Clinical customers
Ended 2015 with record Health & Wellness revenues and
significant reduction in net adjusted EBITDA loss
Expanding delivery model to serve growing markets including
onsite flu vaccines, MinuteClinic®, Tobacco DetectSM and
mental health conditions
Hooper Holmes Solutions Focus On Educating Employees
To Drive Behavior Change To Help PREVENT Those High-
Cost Conditions That Drive Employer Medical Costs Today
COMPANY PROFILE
Hooper Holmes mobilizes a national network of health professionals to provide on-site
health screenings, laboratory testing, risk assessment and sample collection services to
wellness and disease management companies, employers and brokers, government
organizations and academic institutions nationwide. Under the Accountable Health
Solutions brand, the Company combines smart technology, healthcare and behavior change
expertise to offer comprehensive health and wellness programs that improve health,
increase efficiencies and reduce healthcare delivery costs.
COMPANY SNAPSHOT:
Symbol: HH
Recent Close: $0.76*
Exchange: NYSE
52-Wk Range: $0.73 - $2.70
Shares Outst: 11.8M
Market Cap: $9M*
*As of 03/09/17
CORPORATE FACT SHEET
March 2017
On March 8, 2017 Hooper Holmes announced plans to merge with Provant, creating one of the largest,
pure-play health and wellness companies in the United States. Merger expected to close Q2 2017.
Investment Highlights
*(http://www.inc.com/graham-winfrey/best-industries-2016-the-best-industries-for-starting-a-business.html)
**(Ken Research 2012 Internal Analysis)
On a combined basis, 2016
pro-forma annual revenue
of the merged company is
approximately $67.2
million, excluding $3.8
million of pass-through gift
card revenue at Provant.
Value and growth drivers
Combination will create a wellness leader across four
high growth segments
Biometric screenings,
complex blood analysis
Health coaching &
condition management
Well-being portal,
personalized nutrition, sleep,
finance, trackers, challenges
Advanced data management,
analysis, reporting
Innovation capabilities – Driving evidence-based,
actionable screenings and digital interventions
Scale – Large portfolio of clinical screenings and next-
generation digital technologies
Growth in adjacent sales opportunities – Tools and
resources to take advantage of potential sales
opportunities across customer categories
Leverage client and channel relationships –
Complementary sales channels and revenue sources
Hooper - Provant Combined Pro Forma Revenues
Combined pro-forma revenues of $67.2 million in 2016
Annualized synergistic savings of $7+ million
Transaction expected to be accretive to adjusted EBITDA, projected
to be $3 million in last 9 months of 2017, once combined
No overlap of existing customer base
Increases to scale as a combined entity with complementary
strengths in both operations and technology
Significant operational synergies and improved financial
performance
Invest ent Highlights
Company Profile Company Snapshot
Core business solid and
growing
Growth in Channel Partners
revenue reflects strength of
our screening services
Direct sales channel reflects
customers who contract
directly with us for one or
more services. These
contracts are typically multi-
year commitments
Clinical research
organizations contracts are
typically long term in nature
Biometric screenings sold
through all sales channels
Flu shots sold through both
Direct and Channel Partner
sales channels
Core Customer Growth in Q3 2016
PROSPECTIVE MANAGEMENT
TEAM AND BOARD FOR
THE COMBINED COMPANY
________________________________
MANAGING FOR SUCCESS
Henry E. Dubois
President and Chief Executive Officer,
Director
Heather Provino
Chief Strategy Officer
Mark Clermont
President
Steven R. Balthazor
Chief Financial Officer
________________________________
BOARD OF DIRECTORS
Ronald V. Aprahamian
Chairman of the Board
Henry E. Dubois
President and Chief Executive Officer,
Director
Frank Bazos
Director
Larry Ferguson
Director
Stephen Marquardt
Director
Paul Daoust
Director
Thomas A. Watford
Director
________________________________
INVESTOR RELATIONS
Scott Gordon
CORE IR
Tel: (516) 222-2560
Email: scottg@coreir.com
Andrew Berger
S.M. Berger & Company
Tel: (216) 464-6400
Email: andrew@smberger.com
This presentation contains forward-looking statements, as such term is defined in the Private Securities Litigation Reform Act of 1995, concerning the Company’s plans, objectives, goals, strategies, future events or performances, which are not statements of historical fact and can be identified
by words such as: “expect,” “continue,” “should,” “may,” “will,” “project,” “anticipate,” “believe,” “plan,” “goal,” and similar references to future periods. The forward-looking statements contained in this presentation reflect our current beliefs and expectations. Actual results or performance may
differ materially from what is expressed in the forward looking statements. Among the important factors that could cause actual results to differ materially from those expressed in, or implied by, the forward-looking statements contained in this presentation are our ability to realize the expected
benefits from the acquisition of Accountable Health Solutions and our strategic alliance with Clinical Reference Laboratory; our ability to successfully implement our business strategy and integrate Accountable Health Solutions’ business with ours; our ability to retain and grow our customer
base; our ability to recognize operational efficiencies and reduce costs; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to maintain compliance with the financial covenants contained in our credit facilities; the rate of growth in the Health and Wellness
market and such other factors as discussed in Part I, Item 1A, Risk Factors, and Part II, Item 7, Management’s Discussion and Analysis of Financial Conditions and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2015. The Company undertakes no
obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances, or to reflect the occurrence of unanticipated events, after the date of this presentation, except as required by law. This presentation contains information from third-party sources,
including data from studies conducted by others and market data and industry forecasts obtained from industry publications. Although the Company believes that such information is reliable, the Company has not independently verified any of this information and the Company does not
guarantee the accuracy or completeness of this information. Any references to documents not included in the presentation itself are qualified by the full text and content of those documents. During our prepared comments or responses to your questions, we may offer incremental metrics to
provide greater insight into the dynamics of our business or our quarterly results, such as references to EBITDA and other measures of financial performance. Please be advised that this additional detail may be one-time in nature and we may or may not provide an update in the future. These
and other financial measures may also have been prepared on a non-GAAP basis.
Service Mix Enables Ongoing Revenue Recognition
Screening and Coaching
Revenue driven by the
percentage of employees
participating in the Wellness
program; Portal is a recurring
per employee per month fee
Hooper works with clients to
drive program participation
Coaching typically follows
Screenings; both typically recur
annually for new program year
Robust Market Demand
Key Takeaways
Additional Information about the Proposed Merger and Where to Find It
• In connection with the previously disclosed proposed merger with Provant, the
Company has filed a registration statement on Form S-4 with the Securities and
Exchange Commission (the “SEC”) (SEC file number 333-216760), including a proxy
statement/prospectus, but the registration statement has not yet become effective.
Shareholders of the Company are urged to read these materials because they
contain important information about the Company, Provant, and the proposed
merger. The proxy statement/prospectus and other documents filed by the
Company with the SEC may be obtained free of charge at the SEC web site at
www.sec.gov. In addition, investors and security holders may obtain free copies of
the documents filed with the SEC by the Company by directing a written request to:
Hooper Holmes, Inc., 560 N. Rogers Road, Olathe, Kansas 66062, Attention: Legal
Department. Shareholders of the Company are urged to read the proxy
statement/prospectus and the other relevant materials before making any voting or
investment decision with respect to the proposed merger.
• This communication shall not constitute an offer to sell or the solicitation of an offer
to sell or the solicitation of an offer to buy any securities, nor shall there be any sale
of securities in any jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of any such
jurisdiction. No offering of securities in connection with the proposed merger shall
be made except by means of a prospectus meeting the requirements of Section 10 of
the Securities Act of 1933, as amended.
Participants in the Solicitation
• The Company and its directors and executive officers and Provant and its directors
and executive officers may be deemed to be participants in the solicitation of
proxies from the shareholders of the Company in connection with the proposed
merger. Information regarding the special interests of these directors and executive
officers in the merger is included in the proxy statement/prospectus referred to
above. Additional information regarding the directors and executive officers of the
Company is also included in the Company’s Annual Report on Form 10-K for the
year ended December 31, 2016, which is available free of charge at the SEC web
site (www.sec.gov) and from the Company at the address described above.